Suchergebnisse - (Subject:"CK")

PubPharm (1.359)

1

Pembrolizumab with trastuzumab and chemotherapy in advanced or metastatic gastric or gastroesophageal junction adenocarcinomas with surexpression of HER2 and CPS≥1

enthalten in: Bulletin du cancer | 2024

von Lévêque, I. | Spitzer, E.

2

Radiotherapy and targeted therapy for the management of breast cancer : A review

enthalten in: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique | 2023

von Beddok, A. | Cottu, P. | Fourquet, A. | +1

3

Targeted systemic treatments and locoregional radiotherapy for breast cancer : Can we expect a benefit from the potentiation of local treatment?

enthalten in: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique | 2023

von Camps Maléa, A. | Hennequin, C. | Rivera, S.

4

New drug approval : Trastuzumab-deruxtecan in HER2 positive advanced gastric or gastroesophageal junction cancer after previous treatment with trastuzumab

enthalten in: Bulletin du cancer | 2023

von Duval, J. | Zaanan, A.

5

New drugs approval : Trastuzumab-deruxtecan - HER2-low metastatic breast cancer

enthalten in: Bulletin du cancer | 2023

von Gorgeu, V. | Grellety, T.

6

Co-administration of pertuzumab and trastuzumab is practical in home hospitalization

enthalten in: Bulletin du cancer | 2023

von Pailler, C. | Gandrille, N. | Poterre, M. | +2

7

Targeting HER2 in colorectal cancer

enthalten in: Bulletin du cancer | 2023

von Spitzer, E. | Cervera, P. | André, T. | +1

8

Therapeutic advances in HER2+ breast cancer

enthalten in: La Revue du praticien | 2023

von Alexandre, M. | Jacot, W.

9

2022 : New therapeutic practices in breast oncology

enthalten in: Bulletin du cancer | 2023

von Deluche, E. | Verret, B.

10

Scurvy mimicking vasculitis

enthalten in: La Revue du praticien | 2023

von Maillet, C. | Wong So, J. | Ramdani, Y. | +5

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[136]